Healthcare Realty Appoints Daniel Gabbay as CFO, Austen Helfrich Departs
HR sits 21% above its 52-week low of $14.09.
Summary
Healthcare Realty Trust announced the appointment of Daniel Gabbay, a seasoned real estate investment banker, as its new Executive Vice President and Chief Financial Officer, effective January 12, 2026. Current CFO Austen Helfrich will depart amicably.
Key Events · Executive and Board Changes · HR
-
New CFO Appointed
Daniel Gabbay, a former Managing Director at RBC Capital Markets with primary coverage of the healthcare REIT sector, will become Executive Vice President and Chief Financial Officer, effective January 12, 2026.
-
Outgoing CFO Departs Amicably
Austen B. Helfrich will depart as CFO on January 12, 2026. The company stated his separation is not due to any disagreement with management or auditors.
-
Severance Charge
The company expects to record a charge of approximately $5 million for the quarter ended March 31, 2026, in connection with Mr. Helfrich's separation.
-
New CFO Compensation Package
Mr. Gabbay's compensation includes a $500,000 base salary, a target $625,000 annual cash incentive, $1,375,000 in annual equity awards, and a one-time $2,750,000 make-whole restricted stock award vesting over four years.
Analysis · HR · Real Estate & Construction
The appointment of Daniel Gabbay as the new CFO is a significant leadership change for Healthcare Realty. Mr. Gabbay's extensive background in real estate investment banking, particularly with a focus on the healthcare REIT sector, brings valuable expertise to the company's executive team. His experience in advising on large-scale real estate transactions could be beneficial for future strategic initiatives. The departure of the previous CFO, Austen Helfrich, is noted as amicable and not due to any disagreements, which mitigates potential negative concerns. The company expects a $5 million charge related to Mr. Helfrich's separation, which is a minor financial impact for a company of this size. Investors should monitor the integration of the new CFO and any potential shifts in financial strategy or capital markets activities under his leadership.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 29% of the 1653 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.58%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HR was trading at $17.05 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $6B. The 52-week trading range was $14.09 to $18.97. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.